[EN] GRANZYME B INHIBITOR FORMULATIONS AND METHODS FOR THE TREATMENT OF BURNS<br/>[FR] FORMULATIONS INHIBITRICES DE GRANZYME B ET MÉTHODES DE TRAITEMENT DE BRÛLURES
申请人:VIDA THERAPEUTICS INC
公开号:WO2017132771A1
公开(公告)日:2017-08-10
Formulations for treating burns and burn wound healing comprising a Granzyme B inhibitor and a pharmaceutically acceptable carrier, and methods for treating burns and for burn wound healing using the formulations.
[EN] 5-OXO-ETE RECEPTOR ANTAGONIST COMPOUNDS<br/>[FR] COMPOSÉS ANTAGONISTES DES RÉCEPTEURS 5-OXO-ETE
申请人:UNIV MCGILL
公开号:WO2010127452A1
公开(公告)日:2010-11-11
The present invention relates to novel pharmaceutically-useful compounds which are antagonists of the 5-oxo-ETE receptors, such as the OXE receptor. These compounds have use as therapeutic and/or prophylactic agents for diseases characterized by tissue eosinophilia, such as inflammatory conditions including respiratory diseases. The invention also relates to pharmaceutical compositions, to the use of such compounds and compositions as medicaments, and to therapeutic methods.
Oxidative cleavage of cycloalkanones with dioxygen catalyzed by supported catalysts or homogeneous systems: Evidence for novel active ruthenium (II) and/or (III) species
作者:Maxence Vennat、Jean-Marie Brégeault
DOI:10.1016/j.apcata.2010.07.016
日期:2010.9
α-Substituted cycloalkanones are oxidized to oxo-acids by low-nuclearity complexes (Cu2+ or [VO2]+/[VO]2+ – exchanged Nafion® beads), or homogeneous systems with ruthenium acetate complexes and [Ru(H2O)6] (tosylate)2 in dioxygen (0.1 MPa) at 55–60 °C. The catalytic procedures compare well with previously described systems involving homogeneous catalysis with copper (II) or polyoxometalates such as “H8[PMo7V5O40]·aq”
α取代的环烷酮通过低核性复合物(铜氧化成氧代酸2+或[VO 2 ] + / [VO] 2+ -交换的Nafion ®,或用乙酸钌络合物的均相体系和的[Ru(H珠)2 O)6 ](甲苯磺酸酯)2在55–60°C的双氧(0.1 MPa)中。该催化程序与之前所述的涉及用铜(II)或多金属氧酸盐(例如“ H 8 [PMo 7 V 5 O 40]·aq”。在涉及质子和过渡金属盐的情况下,结果补充了广泛使用的氧化方法进行酮裂解。对于这些反应,提出了一种涉及过氧物质的暂定双加氧酶机理。
[EN] 3,28-DISUBSTITUTED BETULINIC ACID DERIVATIVES AS ANTI-HIV AGENTS<br/>[FR] DÉRIVÉS D'ACIDE BÉTULINIQUE 3,28-DISUBSTITUÉS EN TANT QU'AGENTS ANTI-VIH
申请人:UNIV NORTH CAROLINA
公开号:WO2013148067A1
公开(公告)日:2013-10-03
The present invention provides compounds of Formula (I) and Formula (II): along with compositions containing the same and methods of use thereof in treating viral infections such as HIV infections.
Synthesis of 5- and 6-Oxoalkanoic Acids by Copper(II)-Catalyzed Oxidative Cleavage of Cycloalkanones with Dioxygen
作者:Ahmed Atlamsani、Jean-Marie Brégeault
DOI:10.1055/s-1993-25801
日期:——
α-Substituted cycloalkanones are oxidized to oxo acids by the copper(II)/dioxygen/acetic acid/water system. This catalytic procedure compares well with the previously described systems involving vanadium precursors.